TMCnet News
StockEgg.com: StockEgg.com Announces Coverage on FXPE.OB and GTEC.OB(M2 PressWIRE Via Thomson Dialog NewsEdge) RDATE:25102007 StockEgg.com Announces Coverage on FXPE.OB and GTEC.OB Sign up for our FREE Stock Alerts at http://www.stockegg.com On Thursday October 25th, 2007, Fox Petroleum Inc. (OTCBB: FXPE) is trading at 2.15 per share and is up 10.82% on high volume FXPE News: On Thursday October 25th, 2007, Fox Petroleum Inc. (OTCBB: FXPE) announced that they have signed an agreement to acquire approximately 42,000 acres containing the Catcher's Mitt Prospect located in the Cook Inlet region on the south coast of Alaska, adding to their existing 32,000 acre Alaskan North Slope exploration portfolio. Fox has signed an agreement to acquire a 100% working interest in approximately 42,000 acres of high impact gas prospects in the Kenai Peninsula region of Alaska's Cook Inlet. Fox Petroleum's 8 new leases are located onshore, and are in close proximity to many major production sites. Two wells, the BA Bell Island well and the Unocal Figure Eight well, drilled on the structure down-dip demonstrated gas shows. "This major acquisition provides us with a unique opportunity to have immediate impact in the Cook Inlet. The region has a proven gas history, an existing transportation infrastructure and a pressing industrial gas shortage that demands further development and production occur. Fox Petroleum is confident that we can take advantage of the situation to quickly move our development plan forward" states CEO, Richard Moore. About the Cook Inlet The Cook Inlet is a large ocean opening that stretches 180 miles from the Gulf of Alaska to Anchorage in south-central Alaska. The area is home to over 20 producing fields with proven reserves of over 1.6 TCF of gas as of 2006. The Cook Inlet is home to the majority of commercial and residential energy demand in Alaska, with over 330,000 natural gas consumers in the area and growing demand. Recent natural gas supply shortages have encouraged exploration and drilling companies to expedite their development programs, resulting in renewed interest and investment in the region. Agrium, a leading global producer and marketer of agricultural nutrients, industrial products and specialty fertilizers has recently expressed interest to obtain long term gas supply contracts as they have unfortunately been forced to shut down operations at their Kenai plant due to lack of consistent natural gas supply. ConocoPhillips, Aurora Gas, Pioneer Natural Resources, Marathon Oil, Renaissance Alaska LLC and Unocal make up just a few of the region's explorers and producers. About The Catcher's Mitt Prospect The Catcher's Mitt leases are large high impact multi layered gas prospects located on the east coast of the Cook Inlet, West of Anchorage Alaska. The area is experiencing a recent renaissance in infrastructure development and exploration activity. The jointly owned Kenai Kachemak Pipeline developed by Marathon Oil and Chevron (formerly Unocal) runs directly through the property from the city of Kenai, 32 miles south to Ninilchik, with a capacity of 260mmcfd of gas. Recently, the pipeline was extended inland 15 miles to the southeast to connect with Chevron's Happy Valley gas field. Escopeta Oil, an E&P company based out of Texas, has recently extended the distribution infrastructure in their adjacent North Alexander Unit, which they have recently permitted for drilling. Exploration Plans Fox has contracted a Certified Petroleum Geologist named Jerry Hodgden of Hodgden and Associates (Geoscientists) to complete a technical report on the Catcher's Mitt prospect using the existing surface and sub-surface data from the region, in order to facilitate a better understanding of its hydrocarbon potential. It is anticipated that the data analysis period will take 30 to 45 days. Fox hopes to define several test well targets, which could be permitted for drilling in 2008. Given the large amount of activity currently taking place in the surrounding area leases, Fox Petroleum is also considering joint venture drilling opportunities and cost-saving consecutive drilling programs with neighboring gas exploration and drilling companies. Jerry Hodgden stated "Fox Petroleum's Catcher's Mitt Prospect area first came to my attention over three decades ago as a pair of large anticlinal structures with good gas shows at reasonable depths in nearby wells. As the production from the aging Beluga and Kenai Gas Fields is in sharp decline, there is a strong need for new gas reserves in the area, and the Catcher's Mitt structures are in close proximity to a pipeline to Anchorage and to other nearby cities and plants where there is growing demand for this diminishing product. What could be better? A big anticlinal structure close to a pipe line to take gas directly to a ready market where gas is selling for record prices!" About Fox Petroleum Fox Petroleum Inc. is an Oil and Gas Exploration Company headquartered in London, England, the financial capital of Europe. Fox also has an operations office in Anchorage, Alaska. Fox's current targets include mineral rights to 32,000+ acres in Alaska's North Slope estimated to represent a potential of up to 160 million barrels of oil (LAPP Resources, Inc.), and the rights to a 33.33% ownership stake in a 37,000+ acre UK North Sea license which could potentially hold up to 213 million barrels of oil (TRACS International Ltd). The Company's shares are publicly traded on the NASD OTC BB under the ticker symbol FXPE. On Thursday October 25th, 2007, Genesis Technology Group, Inc. (OTCBB: GTEC) is trading at 0.46 per share and is up 31.81% on high volume GTEC News: On Wednesday October 24th, 2007, Genesis Technology Group, Inc. (OTCBB: GTEC) to be known as Genesis Pharmaceutical Enterprises, Inc.) ("GTEC" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), announced that it has retained CCG Elite to design and execute its investor relations campaign. Genesis, through its wholly-owned subsidiary Laiyang Jiangbo Biotech Technologies Co., Ltd. ("JiangBo"), is engaged in the research, development, manufacture and sale of pharmaceutical products in the PRC. One of the major pharmaceutical companies in the PRC, Genesis offers a full product line of both western medical drugs and Chinese herbal-based medical drugs in tablet, capsule and granule forms. For the year ending June 30, 2007, net sales for Genesis totaled $76.2 million, up approximately 55 percent from $49.2 million in 2006. "We are a rapidly growing, large non-state-owned pharmaceutical producer in Shandong Province," said Mr. Cao Wubo, the Chairman and CEO of Genesis Technology Group. "We look forward to working with CCG Elite to increase our visibility in both the investment community and with the financial media as we continue to execute our growth strategy." Pharmaceutical demand in the PRC is forecast to expand by more than 13 percent annually to reach RMB385 billion (about US$51 billion) by 2010. Consumption and production of pharmaceuticals in the PRC is expected to increase rapidly over the long term because of strong economic growth, changing demographic patterns, and the reform and expansion of health care systems. "JiangBo is a large pharmaceuticals producer with products distributed via hospital and medical outlets in China, with an advanced technology, an experienced management team and a strong, competitive marketing presence," said Crocker Coulson, President of CCG Elite. "The company is well-positioned to take advantage of increasing demand for pharmaceuticals in China. We intend to assist the company to develop a broader following with fund managers and analysts focusing on high growth equities from China through an integrated investor relations program." About Genesis Technology Group, Inc. Genesis, through its wholly-owned subsidiary Laiyang Jiangbo Biotech Technologies Co., Ltd. ("JiangBo"), is engaged in the research, development, manufacture and sale of pharmaceutical products in the PRC. One of the major pharmaceutical companies in the PRC, Genesis offers a full product line of both western medical drugs and Chinese herbal-based medical drugs in tablet, capsule and granule forms. Jiangbo has several Certificates of Good Manufacturing Practices for Pharmaceutical Products from the Shandong State Drug Administration, and currently produces 5 major product categories in 3 forms. About StockEgg.com http://www.StockEgg.com is a leading financial communications firm, that provides free alerts on stocks that show various activities, based on volume, news, volatitlity. This press release contains "forward-looking" statements as that term is defined by Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). All statements that are included in this press release other than statements of historical fact are "forward-looking" statements. Although management believes that the expectations reflecting in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Important factors could cause actual results to differ materially from the expectations as disclosed herein, including without limitation, in conjunction with these forward-looking statements contained in this press release. Disclaimer: StockEgg.com "(StockEgg.com)" is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. StockEgg.com profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of StockEgg.com and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and StockEgg.com research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. StockEgg.com disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies ' discussed in this release is highly speculative and carries a high degree of risk. StockEgg.com is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in StockEgg.com profiled stocks. Please be advised that StockEgg.com is often compensated for issuing press release, profiles or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating StockEgg.com's statements regarding a company. StockEgg.com's officers and directors reserve the right to buy additional shares of the company discussed in this opinion and may profit in the event those shares rise in value. When StockEgg.com receives free trading shares as compensation for a profiled company, StockEgg.com may sell part or all of any such shares during the period in which StockEgg.com is performing such services. StockEgg.com will also disclose any compensenation. CONTACT: StockEgg.com e-mail: [email protected] WWW: http://www.StockEgg.com ((M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])). Copyright 2007 M2 Communications Ltd. |